SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock-2 registry.
SCAI stages
cardiogenic shock
heart failure
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
27
09
2022
received:
15
07
2022
accepted:
02
11
2022
pubmed:
16
11
2022
medline:
21
1
2023
entrez:
15
11
2022
Statut:
ppublish
Résumé
Cardiogenic shock (CS) includes several phenotypes with heterogenous hemodynamic features. Timely prognostication is warranted to identify patients requiring treatment escalation. We explored the association of the updated Society for Cardiovascular Angiography and Interventions (SCAI) stages classification with in-hospital mortality using a prospective national registry. Between March 2020 and February 2022 the Altshock-2 Registry has included 237 patients with CS of all etiologies at 11 Italian Centers. Patients were classified according to their admission SCAI stage (assigned prospectively and independently updated according to the recently released version). In-hospital mortality was evaluated for association with both admission and 24-h SCAI stages. The overall in-hospital mortality was 38%. Of the 237 patients included and staged according to the updated SCAI classification, 20 (8%) had SCAI shock stage B, 131 (55%) SCAI stage C, 61 (26%) SCAI stage D and 25 (11%) SCAI stage E. In-hospital mortality stratified according to the SCAI classification at 24 h was 18% for patients in SCAI stage B, 27% for SCAI stage C, 63% for SCAI stage D and 100% for SCAI stage E. Both the revised SCAI stages on admission and at 24 h were associated with in-hospital mortality, but the classification potential slightly increased at 24-h. After adjusting for age, sex, lactate level, eGFR, CVP, inotropic score and mechanical circulatory support [MCS], SCAI classification at 24 h was an independent predictor of in-hospital mortality. In the Altshock-2 registry the utility of SCAI shock stages to identify risk of in-hospital mortality increased at 24 h after admission. Escalation of treatment (either pharmacological or with MCS) should be tailored to achieve prompt clinical improvement within the first 24 h after admission. Registration: http://www. gov; Unique identifier: NCT04295252.
Sections du résumé
BACKGROUND
Cardiogenic shock (CS) includes several phenotypes with heterogenous hemodynamic features. Timely prognostication is warranted to identify patients requiring treatment escalation. We explored the association of the updated Society for Cardiovascular Angiography and Interventions (SCAI) stages classification with in-hospital mortality using a prospective national registry.
METHODS
Between March 2020 and February 2022 the Altshock-2 Registry has included 237 patients with CS of all etiologies at 11 Italian Centers. Patients were classified according to their admission SCAI stage (assigned prospectively and independently updated according to the recently released version). In-hospital mortality was evaluated for association with both admission and 24-h SCAI stages.
RESULTS
The overall in-hospital mortality was 38%. Of the 237 patients included and staged according to the updated SCAI classification, 20 (8%) had SCAI shock stage B, 131 (55%) SCAI stage C, 61 (26%) SCAI stage D and 25 (11%) SCAI stage E. In-hospital mortality stratified according to the SCAI classification at 24 h was 18% for patients in SCAI stage B, 27% for SCAI stage C, 63% for SCAI stage D and 100% for SCAI stage E. Both the revised SCAI stages on admission and at 24 h were associated with in-hospital mortality, but the classification potential slightly increased at 24-h. After adjusting for age, sex, lactate level, eGFR, CVP, inotropic score and mechanical circulatory support [MCS], SCAI classification at 24 h was an independent predictor of in-hospital mortality.
CONCLUSIONS
In the Altshock-2 registry the utility of SCAI shock stages to identify risk of in-hospital mortality increased at 24 h after admission. Escalation of treatment (either pharmacological or with MCS) should be tailored to achieve prompt clinical improvement within the first 24 h after admission. Registration: http://www.
CLINICALTRIALS
gov; Unique identifier: NCT04295252.
Identifiants
pubmed: 36378673
doi: 10.1002/ccd.30484
pmc: PMC10100478
doi:
Banques de données
ClinicalTrials.gov
['NCT04295252']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
22-32Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC.
Références
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):117-25
pubmed: 26884615
Eur J Heart Fail. 2015 May;17(5):501-9
pubmed: 25820680
J Am Coll Cardiol. 2018 Oct 16;72(16):1972-1980
pubmed: 30309475
Catheter Cardiovasc Interv. 2020 Dec;96(7):1339-1347
pubmed: 33026155
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):29-37
pubmed: 31104355
J Am Heart Assoc. 2019 Apr 16;8(8):e011991
pubmed: 30947630
Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e005618
pubmed: 30879324
J Am Coll Cardiol. 2022 Mar 8;79(9):933-946
pubmed: 35115207
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
G Ital Cardiol (Rome). 2017 Oct;18(10):719-726
pubmed: 29105686
Circ Heart Fail. 2020 Sep;13(9):e007099
pubmed: 32900234
Catheter Cardiovasc Interv. 2023 Jan;101(1):22-32
pubmed: 36378673
J Am Heart Assoc. 2014 Jan 13;3(1):e000590
pubmed: 24419737
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):E213-E219
pubmed: 31925996